Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / March / Toxicant Exposure Echoes for Generations
Biochemistry and molecular biology Genetics and epigenetics Research and Innovations

Toxicant Exposure Echoes for Generations

Study tracks epigenetic inheritance, organ pathology, and reproductive complications across maternal and paternal lineages

03/03/2026 News 2 min read

Share

Credit: Background image sourced from Adobe Stock

A 20-generation rat study has reported stable transmission of environmentally induced epigenetic changes associated with adult-onset disease and abnormal births, highlighting potential long-term implications for reproductive and diagnostic research.

In a research article published in Proceedings of the National Academy of Sciences, investigators extended earlier multigenerational work by following rat lineages ancestrally exposed to the fungicide vinclozolin through 20 generations. Prior studies had demonstrated epigenetic transgenerational inheritance through 10 generations; this study examined whether those changes persisted over a longer time frame and whether new pathologic findings emerged.

In the model, gestating F0 females were exposed to vinclozolin. Subsequent generations were bred without additional exposure. The investigators assessed disease incidence, reproductive outcomes, germline changes, and DNA methylation patterns in both maternal and paternal lineages.

Genome-wide analysis identified persistent differential DNA methylated regions (DMRs) across generations, with an overall increase in DMRs observed over time. Molecular profiling was performed using methylated DNA immunoprecipitation sequencing, and data were deposited in a public repository (GEO #GSE318059).

Germline effects were evaluated using deoxyuridine triphosphate nick end labeling assays. Increased levels of apoptosis were detected in male germ cells in both maternal and paternal lineages, suggesting potential effects on spermatogenesis.

Pathologic assessment demonstrated increased incidence of adult-onset disease involving multiple organs, including kidney, testis, ovary, and prostate. After approximately 16 generations, abnormal births were observed in ancestrally exposed lineages, including maternal deaths during labor and stillbirths. These findings had not been reported in earlier generations.

The study design distinguished direct exposure effects from transgenerational effects by focusing on generations not directly exposed to the toxicant. Both maternal and paternal lines demonstrated transmission of epigenetic alterations and associated phenotypes.

Although direct translation to human disease requires caution, the authors note that the results are relevant to ongoing discussions about environmental exposures, reproductive health, and disease susceptibility.

Lead researcher, Michael Skinner, a biologist at Washington State University, explained, “In humans, we've actually got epigenetic biomarkers for about 10 different disease susceptibilities. It doesn't say you have the disease now, it says 20 years from now, you're potentially going to get this disease. There's a whole series of preventative medicine approaches that can be taken before the disease develops to delay or prevent the disease from happening.”

Further studies will be needed to clarify mechanisms and determine clinical implications.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.